{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:09:29Z","timestamp":1793653769271,"version":"4.5.1"},"reference-count":262,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacc.2025.08.086","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:23:04Z","timestamp":1760541784000},"page":"1900-1916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chronic Kidney Disease in Patients With Heart Failure With a Preserved Ejection Fraction"],"prefix":"10.1016","volume":"86","author":[{"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Testani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.08.086_bib1","first-page":"108","article-title":"Cardiorenal disease and heart failure with preserved ejection fraction: two sides of the same coin","volume":"15","author":"N\u00fa\u00f1ez-Mar\u00edn","year":"2025","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pcad.2023.07.003","article-title":"Insight into different phenotypic presentations of heart failure with preserved ejection fraction","volume":"79","author":"Bashir","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2025.08.086_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2016.4652","article-title":"Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: an analysis of 3 community-based cohort studies","volume":"2","author":"Bansal","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.086_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011173","article-title":"Risk factors and outcomes associated with heart failure with preserved and reduced ejection fraction in people with chronic kidney disease","volume":"17","author":"Bansal","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jchf.2023.01.029","article-title":"Chronic kidney disease, heart failure, and adverse cardiac remodeling in older adults: the ARIC study","volume":"11","author":"Buckley","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib6","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","article-title":"Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"35","author":"Gori","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.086_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.445","article-title":"Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction","volume":"18","author":"Unger","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jchf.2024.11.007","article-title":"Outcomes of KDIGO-defined CKD in U.S. veterans with HFpEF, HFmrEF, and HFrEF","volume":"13","author":"Patel","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.086_bib10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"L\u00f6fman","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jacc.2024.11.007","article-title":"Systolic blood pressure and pulse pressure in heart failure: pooled participant-level analysis of 4 trials","volume":"85","author":"Lu","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCHEARTFAILURE.112.968594","article-title":"Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study","volume":"5","author":"Mohammed","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib13","first-page":"17","article-title":"An age-calibrated definition of chronic kidney disease: rationale and benefits","volume":"37","author":"Delanaye","year":"2016","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jacc.2025.08.086_bib14","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/ndt\/gfr323","article-title":"Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study","volume":"26","author":"Stengel","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2025.08.086_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.amjcard.2013.09.029","article-title":"Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction","volume":"113","author":"Testani","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib16","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1681\/ASN.2019030238","article-title":"CKD: a call for an age-adapted definition","volume":"30","author":"Delanaye","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12933-025-02708-6","article-title":"Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction","volume":"24","author":"Vranken","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2025.08.086_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamacardio.2022.4210","article-title":"Dapagliflozin and kidney outcomes in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the DELIVER randomized clinical trial","volume":"8","author":"Mc Causland","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.2857","article-title":"Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from the EMPEROR-Preserved trial","volume":"25","author":"Sharma","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.jacc.2025.08.086_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.004962","article-title":"Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial","volume":"11","author":"Solomon","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jchf.2024.08.022","article-title":"Angiotensin receptor neprilysin inhibition and cardiovascular outcomes across the kidney function spectrum: the PARAGON-HF trial","volume":"13","author":"Mc Causland","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib22","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMc2112411","article-title":"Empagliflozin and major renal outcomes in heart failure","volume":"385","author":"Packer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2478\/ams-2013-0020","article-title":"Creatinine or cystatin C - which is a better index of renal function in morbid obesity?","volume":"58","author":"Mysliwiec","year":"2013","journal-title":"Adv Med Sci"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12882-017-0474-0","article-title":"Effect of large weight reductions on measured and estimated kidney function","volume":"18","author":"von Scholten","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ki.2014.112","article-title":"The body composition and excretory burden of lean, obese, and severely obese individuals has implications for the assessment of chronic kidney disease","volume":"86","author":"Fotheringham","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.08.086_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1053\/j.jrn.2023.01.012","article-title":"Cystatin C and creatinine concentrations are uninformative biomarkers of sarcopenia: a cross-sectional NHANES Study","volume":"33","author":"Shah","year":"2023","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.jacc.2025.08.086_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1515\/cclm-2017-0563","article-title":"GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults","volume":"56","author":"Bj\u00f6rk","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.08.086_bib29","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/oby.2009.96","article-title":"Potential contribution of adipose tissue to elevated serum cystatin C in human obesity","volume":"17","author":"Naour","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.jacc.2025.08.086_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/j.pbj.0000000000000233","article-title":"Chronic kidney disease prevalence in asymptomatic patients with risk factors-usefulness of serum cystatin C: a cross-sectional study","volume":"8","author":"Avila","year":"2023","journal-title":"Porto Biomed J"},{"key":"10.1016\/j.jacc.2025.08.086_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.xkme.2020.08.008","article-title":"Performance of glomerular filtration rate estimating equations before and after bariatric surgery","volume":"2","author":"Chang","year":"2020","journal-title":"Kidney Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib32","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/oby.22574","article-title":"Estimated glomerular filtration rate bias in participants with severe obesity regardless of deindexation","volume":"27","author":"Guebre-Egziabher","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacc.2025.08.086_bib33","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jacc.2025.03.009","article-title":"Interplay of chronic kidney disease and the effects of tirzepatide in patients with heart failure, preserved ejection fraction, and obesity: the SUMMIT trial","volume":"85","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib34","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/dom.13668","article-title":"Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)","volume":"21","author":"Tuttle","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2025.08.086_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00392-008-0732-z","article-title":"Differential associations between renal function and \"modifiable\" risk factors in patients with chronic heart failure","volume":"98","author":"Smilde","year":"2009","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib36","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","article-title":"Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction","volume":"9","author":"Damman","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/eurjhf\/hfq118","article-title":"Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality","volume":"12","author":"Damman","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10741-011-9233-7","article-title":"A re-appraisal of volume status and renal function impairment in chronic heart failure: combined effects of pre-renal failure and venous congestion on renal function","volume":"17","author":"Sinkeler","year":"2012","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2025.08.086_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000494089","article-title":"Echocardiographic and hemodynamic parameters associated with diminishing renal filtration among patients with heart failure with preserved ejection fraction","volume":"9","author":"Lo","year":"2019","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/eurjhf\/hfs209","article-title":"Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment","volume":"15","author":"Dupont","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib43","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.ekir.2024.07.009","article-title":"Peak tricuspid regurgitation jet velocity and kidney outcomes in patients with heart failure with preserved ejection fraction","volume":"9","author":"Oka","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"14","key":"10.1016\/j.jacc.2025.08.086_bib44","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/diagnostics14141576","article-title":"Right ventricular and right atrial strain are associated with kidney dysfunction in acute heart failure","volume":"14","author":"Anastasiou","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jacc.2025.08.086_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jchf.2021.12.005","article-title":"Renal compression in heart failure: the renal tamponade hypothesis","volume":"10","author":"Boorsma","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.CIR.74.4.766","article-title":"Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system","volume":"74","author":"Packer","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.086_bib47","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.HYP.0000120964.22281.3e","article-title":"How does angiotensin II cause renal injury?","volume":"43","author":"Long","year":"2004","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.jacc.2025.08.086_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007421","article-title":"Renal sympathetic denervation in patients with heart failure with preserved ejection fraction","volume":"14","author":"Kresoja","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib49","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2017.08.056","article-title":"Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney","volume":"70","author":"Polhemus","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.23876\/j.krcp.18.0143","article-title":"Renal sympathetic nerve activation via alpha(2)-adrenergic receptors in chronic kidney disease progression","volume":"38","author":"Jang","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.jacc.2025.08.086_bib51","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.ajkd.2022.04.016","article-title":"Aldosterone, mineralocorticoid receptor activation, and CKD: a review of evolving treatment paradigms","volume":"80","author":"Epstein","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.08.086_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.680213","article-title":"Protective renal effects of atrial natriuretic peptide: where are we now?","volume":"12","author":"Choi","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib53","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1097\/HJH.0000000000000635","article-title":"The utility of renal venous renin studies in selection of patients with renal artery stenosis for angioplasty: a retrospective study","volume":"33","author":"Goupil","year":"2015","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.jacc.2025.08.086_bib54","first-page":"S287","article-title":"Use of captopril in the diagnostic work-up of renovascular hypertension","volume":"3","author":"Derkx","year":"1985","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.jacc.2025.08.086_bib55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0735-1097(87)80278-4","article-title":"Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure","volume":"10","author":"Packer","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00862057","article-title":"Renal artery stenosis in infants: long-term medical treatment before surgery","volume":"10","author":"Bendel-Stenzel","year":"1996","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2025.08.086_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000174559","article-title":"Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failure","volume":"76","author":"Packer","year":"1989","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2025.08.086_bib58","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-106-3-346","article-title":"Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure","volume":"106","author":"Packer","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cardfail.2019.09.015","article-title":"Adverse renal response to decongestion in the obese phenotype of heart failure with preserved ejection fraction","volume":"26","author":"Reddy","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib60","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ejhf.3136","article-title":"Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved","volume":"26","author":"Rastogi","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2024.11.020","article-title":"Initial decline in glomerular filtration rate with finerenone in HFmrEF\/HFpEF: a prespecified analysis of FINEARTS-HF","volume":"85","author":"Matsumoto","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib62","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCULATIONAHA.123.065748","article-title":"Blinded withdrawal of long-term randomized treatment with empagliflozin or placebo in patients with heart failure","volume":"148","author":"Packer","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacc.2025.08.086_bib63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2410659","article-title":"Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes","volume":"393","author":"Agarwal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0735-1097(88)90371-3","article-title":"Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure","volume":"12","author":"Molina","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.086_bib66","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.086_bib67","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ijo.2010.227","article-title":"Neprilysin, obesity and the metabolic syndrome","volume":"35","author":"Standeven","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jacc.2025.08.086_bib68","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ejhf.2421","article-title":"Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure","volume":"24","author":"Mc Causland","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib69","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib70","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cardfail.2016.09.006","article-title":"Progression of renal impairment and chronic kidney disease in chronic heart failure: an analysis from GISSI-HF","volume":"23","author":"Damman","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cardfail.2020.01.010","article-title":"Impact of continuous flow left ventricular assist device therapy on chronic kidney disease: a longitudinal multicenter study","volume":"26","author":"Yalcin","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.hlc.2013.07.021","article-title":"Hepatic and renal function with successful long-term support on a continuous flow left ventricular assist device","volume":"23","author":"Deo","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jacc.2025.08.086_bib73","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.108.814863","article-title":"Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device","volume":"120","author":"Russell","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.086_bib74","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib75","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib76","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1159\/000502874","article-title":"Association of chronic kidney disease with preserved ejection fraction heart failure is independent of baseline cardiac function","volume":"44","author":"Mavrakanas","year":"2019","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"10.1016\/j.jacc.2025.08.086_bib77","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011598","article-title":"Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction","volume":"18","author":"Yang","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib78","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/eurheartj\/ehae868","article-title":"Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years","volume":"46","author":"van Essen","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.086_bib79","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib80","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jacc.2023.08.026","article-title":"Dapagliflozin in patients with heart failure and deterioration in renal function","volume":"82","author":"Chatur","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib82","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/01.HYP.0000069699.92349.8C","article-title":"Blood pressure predicts risk of developing end-stage renal disease in men and women","volume":"41","author":"Tozawa","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.086_bib83","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jacc.2025.08.086_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215362","article-title":"Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.086_bib85","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jacc.2025.08.086_bib86","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.19604","article-title":"Intensive systolic blood pressure reduction and kidney and cardiovascular outcomes: a secondary analysis of a randomized clinical trial","volume":"8","author":"Sun","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2025.08.086_bib87","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.08.086_bib88","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2337\/dc22-2040","article-title":"Effects of intensive systolic blood pressure lowering on end-stage kidney disease and kidney function decline in adults with type 2 diabetes mellitus and cardiovascular risk factors: a post hoc analysis of ACCORD-BP and SPRINT","volume":"46","author":"Tawfik","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.08.086_bib89","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004872-200103000-00020","article-title":"Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension","volume":"19","author":"Voyaki","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.08.086_bib90","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study","volume":"12","author":"Ruilope","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib91","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"REIN-2 Study Group. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.086_bib92","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib93","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.086_bib94","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jacc.2025.08.086_bib95","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.121.16505","article-title":"SPRINT-a kidney-centric narrative review: recent advances in hypertension","volume":"78","author":"Hu","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.086_bib96","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib97","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.jacc.2024.08.034","article-title":"Why has it been challenging to modify kidney disease progression in patients with heart failure?","volume":"84","author":"Vaduganathan","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib98","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/ki.1996.527","article-title":"Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study","volume":"50","author":"Krolewski","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.08.086_bib99","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199910073411506","article-title":"Nephropathy in patients with type 2 diabetes mellitus","volume":"341","author":"Ritz","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib100","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.ajkd.2009.11.013","article-title":"Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis","volume":"55","author":"Sarafidis","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacc.2025.08.086_bib101","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1681\/ASN.2007060678","article-title":"Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease","volume":"19","author":"Schneider","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib102","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/dc07-1868","article-title":"Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial","volume":"31","author":"DREAM Trial Investigators","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.08.086_bib103","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/dc16-1415","article-title":"Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: outcomes from TECOS","volume":"39","author":"Cornel","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.08.086_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/dc16-0621","article-title":"Effect of saxagliptin on renal outcomes in the SAVOR-TIMI 53 trial","volume":"40","author":"Mosenzon","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.08.086_bib105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib107","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib108","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22848-z","article-title":"Comparison of adiposity anthropometric indices and their associations with visceral fat levels determined by bioelectrical impedance analysis among diabetic patients","volume":"12","author":"Tuglo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2025.08.086_bib110","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1111\/dom.16492","article-title":"The association between the visceral obesity indices and the future diabetes mellitus risk: a prospective cohort study","volume":"27","author":"Zhang","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib111","article-title":"Waist-to-hip ratio better reflect beta-cell function and predicts diabetes risk in adult with overweight or obesity","volume":"57","author":"Liu","year":"2025","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.jacc.2025.08.086_bib112","doi-asserted-by":"crossref","DOI":"10.1177\/03000605251348229","article-title":"Association between long-term changes in obesity-related anthropometric indicators and the risk of type 2 diabetes mellitus in the older population","volume":"53","author":"Xu","year":"2025","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jacc.2025.08.086_bib113","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.numecd.2024.06.019","article-title":"Longitudinal associations of DXA-measured visceral adipose tissue and cardiometabolic risk in middle-to-older aged adults","volume":"34","author":"Zhu","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2025.08.086_bib114","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI115068","article-title":"Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity","volume":"87","author":"Garvey","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2025.08.086_bib115","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"Abel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2025.08.086_bib116","doi-asserted-by":"crossref","first-page":"E551","DOI":"10.1152\/ajpendo.00116.2005","article-title":"Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle","volume":"289","author":"Carvalho","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.jacc.2025.08.086_bib117","doi-asserted-by":"crossref","first-page":"350","DOI":"10.21037\/atm.2017.06.69","article-title":"Association of obesity with hypertension","volume":"5","author":"Aronow","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","article-title":"Incidence and precursors of hypertension in young adults: the Framingham Offspring Study","volume":"16","author":"Garrison","year":"1987","journal-title":"Prev Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib119","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.08.086_bib120","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","article-title":"Obesity, kidney dysfunction and hypertension: mechanistic links","volume":"15","author":"Hall","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib121","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.086_bib122","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10157-010-0298-8","article-title":"Activation of the aldosterone\/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome","volume":"14","author":"Nagase","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib123","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib124","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.jacc.2025.08.086_bib125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib126","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","article-title":"Adipokines and insulin resistance","volume":"14","author":"Rabe","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib127","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fendo.2013.00071","article-title":"Adipokines mediate inflammation and insulin resistance","volume":"4","author":"Kwon","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacc.2025.08.086_bib128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/vhrm.2006.2.2.163","article-title":"Leptin and hypertension in obesity","volume":"2","author":"Bravo","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jacc.2025.08.086_bib129","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.HYP.0000222368.43759.a1","article-title":"Adiponectin replenishment ameliorates obesity-related hypertension","volume":"47","author":"Ohashi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.086_bib130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib131","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib132","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/HJH.0000000000000526","article-title":"Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients","volume":"33","author":"Bonfils","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.08.086_bib133","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1007\/s11695-023-06741-w","article-title":"Sex-specific changes in body composition following metabolic and bariatric surgery are associated with the remission of metabolic syndrome","volume":"33","author":"Yi","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2025.08.086_bib134","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","article-title":"Obesity and chronic kidney disease","volume":"324","author":"Jiang","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.08.086_bib135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib136","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","article-title":"Body mass index and the risk of development of end-stage renal disease in a screened cohort","volume":"65","author":"Iseki","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.08.086_bib137","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: a systematic review and meta-analysis","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib138","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13656","article-title":"Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: a systematic review and meta-analysis","volume":"25","author":"Iqbal","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2025.08.086_bib139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D'Agati","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib140","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/16.9.1790","article-title":"Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis","volume":"16","author":"Praga","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2025.08.086_bib141","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/cvr\/cvaa336","article-title":"Obesity, kidney dysfunction, and inflammation: interactions in hypertension","volume":"117","author":"Hall","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2025.08.086_bib142","doi-asserted-by":"crossref","first-page":"F1629","DOI":"10.1152\/ajprenal.00263.2013","article-title":"Adipokines as a link between obesity and chronic kidney disease","volume":"305","author":"Briffa","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib143","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/jrms.JRMS_1115_17","article-title":"The complex effects of adipokines in the patients with kidney disease","volume":"23","author":"Vahdat","year":"2018","journal-title":"J Res Med Sci"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117828","article-title":"Longitudinal association between serum leptin concentration and glomerular filtration rate in humans","volume":"10","author":"Pedone","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.086_bib145","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/269532","article-title":"Relationship between plasma leptin level and chronic kidney disease","volume":"2012","author":"Shankar","year":"2012","journal-title":"Int J Nephrol"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib146","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12882-018-1026-y","article-title":"Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study","volume":"19","author":"Mwasongwe","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib147","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1523-1755.1999.00626.x","article-title":"Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis","volume":"56","author":"Wolf","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.08.086_bib148","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000095328","article-title":"Leptin and renal fibrosis","volume":"151","author":"Wolf","year":"2006","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib149","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jcsm.13475","article-title":"Adiponectin-to-leptin ratio and incident chronic kidney disease: Sex and body composition-dependent association","volume":"15","author":"Park","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jacc.2025.08.086_bib150","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/JOE-13-0578","article-title":"The role of adiponectin in renal physiology and development of albuminuria","volume":"221","author":"Christou","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jacc.2025.08.086_bib151","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.18632\/aging.102811","article-title":"Adiponectin in renal fibrosis","volume":"12","author":"Jing","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jacc.2025.08.086_bib152","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1159\/000481612","article-title":"Protective effects of adiponectin against diabetic renal injury in a mouse model of diabetes","volume":"43","author":"Hu","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jacc.2025.08.086_bib153","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/157340310790231644","article-title":"Leptin and the regulation of renal sodium handling and renal Na-transporting ATPases: role in the pathogenesis of arterial hypertension","volume":"6","author":"Be\u0142towski","year":"2010","journal-title":"Curr Cardiol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2025.08.086_bib154","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jash.2016.06.013","article-title":"Loss of adiponectin-induced renal sodium excretion in hypertension","volume":"10","author":"Huang","year":"2016","journal-title":"J Am Soc Hypertens"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41387-020-00132-1","article-title":"Alleviation of salt-induced exacerbation of cardiac, renal, and visceral fat pathology in rats with metabolic syndrome by surgical removal of subcutaneous fat","volume":"10","author":"Aoyama","year":"2020","journal-title":"Nutr Diabetes"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280766","article-title":"Association of intraabdominal fat with the risk of incident chronic kidney disease according to body mass index among Korean adults","volume":"18","author":"Lee","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.086_bib157","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41440-021-00719-w","article-title":"Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism","volume":"44","author":"Haze","year":"2021","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jacc.2025.08.086_bib158","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10157-021-02029-4","article-title":"Impact of visceral fat area in patients with chronic kidney disease","volume":"25","author":"Manabe","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib159","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/ndt\/gfx230","article-title":"Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study","volume":"33","author":"Olivo","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2025.08.086_bib160","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2215\/CJN.07010716","article-title":"Comparison between different measures of body fat with kidney function decline and incident CKD","volume":"12","author":"Madero","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib161","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1093\/ndt\/gfq634","article-title":"Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus","volume":"26","author":"Kim","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2025.08.086_bib162","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.jrn.2019.09.002","article-title":"The separate contributions of visceral fat and liver fat to chronic kidney disease-related renal outcomes","volume":"30","author":"Dekkers","year":"2020","journal-title":"J Ren Nutr"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088873","article-title":"Waist to height ratio is an independent predictor for the incidence of chronic kidney disease","volume":"9","author":"Odagiri","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311547","article-title":"Association between anthropometric indices and chronic kidney disease: Insights from NHANES 2009-2018","volume":"20","author":"Chen","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.086_bib165","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2169\/internalmedicine.6235-20","article-title":"The association between anthropometric indices of obesity and chronic kidney disease in middle-aged Japanese men and women: a cohort study","volume":"60","author":"Yamasaki","year":"2021","journal-title":"Intern Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib166","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13690-019-0379-4","article-title":"Waist height ratio predicts chronic kidney disease: a systematic review and meta-analysis, 1998-2019","volume":"77","author":"Liu","year":"2019","journal-title":"Arch Public Health"},{"issue":"25","key":"10.1016\/j.jacc.2025.08.086_bib167","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003769","article-title":"The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults","volume":"95","author":"He","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.086_bib168","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000545356","article-title":"Association of obesity-related indices with rapid kidney function decline and chronic kidney disease: a study from a large longitudinal cohort in China","volume":"18","author":"Yang","year":"2025","journal-title":"Obes Facts"},{"key":"10.1016\/j.jacc.2025.08.086_bib169","article-title":"CKD Prognosis Consortium (CKD-PC). Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium","volume":"364","author":"Chang","year":"2019","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jacc.2025.08.086_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.03.042","article-title":"Obesity and risk of kidney outcomes in heart failure with preserved ejection fraction: a participant-level pooled analysis of 4 contemporary trials","volume":"13","author":"Lassen","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib171","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13845","article-title":"Causality of visceral adipose tissue on chronic kidney disease and renal function measure indicators, and mediation role of hypertension: Mendelian randomization study","volume":"26","author":"Gao","year":"2025","journal-title":"Obes Rev"},{"key":"10.1016\/j.jacc.2025.08.086_bib172","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/db20-1031","article-title":"Perirenal fat thickness is significantly associated with the risk for development of chronic kidney disease in patients with diabetes","volume":"70","author":"Chen","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2025.08.086_bib173","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10334-019-00773-z","article-title":"Renal sinus fat and renal hemodynamics: a cross-sectional analysis","volume":"33","author":"Spit","year":"2020","journal-title":"MAGMA"},{"key":"10.1016\/j.jacc.2025.08.086_bib174","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/HYPERTENSIONAHA.111.175315","article-title":"Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study","volume":"58","author":"Foster","year":"2011","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jacc.2025.08.086_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101583","article-title":"Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance","volume":"50","author":"Chen","year":"2024","journal-title":"Diabetes Metab"},{"issue":"10","key":"10.1016\/j.jacc.2025.08.086_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293464","article-title":"Para-perirenal fat thickness is associated with reduced glomerular filtration rate regardless of other obesity-related indicators in patients with type 2 diabetes mellitus","volume":"18","author":"Xu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.086_bib177","doi-asserted-by":"crossref","first-page":"36","DOI":"10.36628\/ijhf.2022.0029","article-title":"Perirenal fat and kidney function deterioration in patients with acute decompensated heart failure","volume":"5","author":"Cho","year":"2023","journal-title":"Int J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib178","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jchf.2023.06.027","article-title":"Perirenal adipose tissue is associated with renal dysfunction and abnormal hemodynamics in patients with HFpEF","volume":"11","author":"Boorsma","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib179","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000538996","article-title":"Effect of liraglutide in different abdominal fat layers measured by ultrasound: the importance of perirenal fat reduction","volume":"17","author":"Cuatrecasas","year":"2024","journal-title":"Obes Facts"},{"issue":"10","key":"10.1016\/j.jacc.2025.08.086_bib180","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/jch.13370","article-title":"Morbid obesity and hypertension: the role of perirenal fat","volume":"20","author":"Ricci","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jacc.2025.08.086_bib181","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ckj\/sfaa266","article-title":"Renoprotective role of bariatric surgery in patients with established chronic kidney disease","volume":"14","author":"Morales","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jacc.2025.08.086_bib182","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/2047487319851298","article-title":"Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction","volume":"26","author":"Campbell","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib183","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002711","article-title":"Adiposity, fat-free mass and incident heart failure in 500 000 individuals","volume":"11","author":"Oguntade","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2025.08.086_bib184","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","article-title":"Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Rao","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"25","key":"10.1016\/j.jacc.2025.08.086_bib185","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity and its prognostic significance in heart failure with mildly reduced or preserved ejection fraction: the PARAGON-HF trial","volume":"46","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.086_bib186","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jacc.2024.10.111","article-title":"Finerenone, obesity, and heart failure with mildly reduced\/preserved ejection fraction: prespecified analysis of FINEARTS-HF","volume":"85","author":"Butt","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib187","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2025.03.530","article-title":"Disentangling the impact of adiposity from insulin resistance in heart failure with preserved ejection fraction","volume":"85","author":"Reddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib188","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib189","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacc.2025.08.086_bib190","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/ehf2.13382","article-title":"Visceral adiposity, muscle composition, and exercise tolerance in heart failure with preserved ejection fraction","volume":"8","author":"Ying","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib191","article-title":"Clinical features, myocardial strain and tissue characteristics of heart failure with preserved ejection fraction in patients with obesity: a prospective cohort study","volume":"55","author":"He","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jacc.2025.08.086_bib192","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ejhf.2291","article-title":"Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction","volume":"23","author":"Kresoja","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.jacc.2025.08.086_bib193","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002883","article-title":"Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women","volume":"9","author":"Eaton","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soard.2021.09.009","article-title":"Bariatric surgery decreases the number of future hospital admissions for diastolic heart failure in subjects with severe obesity: a retrospective analysis of the US National Inpatient Sample database","volume":"18","author":"Romero Funes","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jacc.2025.08.086_bib195","first-page":"625","article-title":"Epicardial adipose tissue in heart failure phenotypes - a meta-analysis","volume":"118","author":"Correia","year":"2022","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib196","first-page":"579","article-title":"Exploring the intriguing relationship: epicardial adipose tissue correlation with left atrial and left ventricular function across different heart failure types","volume":"73(5)","author":"Wang","year":"2025","journal-title":"Minerva Cardiol Angiol"},{"issue":"18","key":"10.1016\/j.jacc.2025.08.086_bib197","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.3390\/jcm13185533","article-title":"Epicardial fat in heart failure with preserved ejection fraction compared with reduced ejection fraction","volume":"13","author":"Sidhu","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib198","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1002\/ehf2.14483","article-title":"Diverging role of epicardial adipose tissue across the entire heart failure spectrum","volume":"10","author":"Rossi","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib199","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/ejhf.2513","article-title":"Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction","volume":"24","author":"Jin","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib200","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/ejhf.2337","article-title":"Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure","volume":"23","author":"Pugliese","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.jacc.2025.08.086_bib201","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","article-title":"Tirzepatide reduces LV mass and paracardiac adipose tissue in obesity-related heart failure: SUMMIT CMR substudy","volume":"85","author":"Kramer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib202","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib203","first-page":"208","article-title":"The lymphatic drainage of the parietal pericardium in man","volume":"28","author":"Eliskova","year":"1995","journal-title":"Lymphology"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib204","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12872-024-04118-0","article-title":"Abdominal obesity is associated with increased worsening renal function risk in patients with heart failure with preserved ejection fraction","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.08.086_bib205","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(24)01498-3","article-title":"Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial","volume":"404","author":"Deanfield","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.086_bib206","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/CIRCULATIONAHA.116.022249","article-title":"Heart failure with preserved ejection fraction: a kidney disorder?","volume":"134","author":"Fang","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.086_bib207","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037051","article-title":"Association of kidney function with incident heart failure: an analysis of the women's health initiative","volume":"14","author":"Cheng","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.086_bib208","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2215\/CJN.02700316","article-title":"Associations of conventional echocardiographic measures with incident heart failure and mortality: the Chronic Renal Insufficiency Cohort","volume":"12","author":"Dubin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib209","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12872-024-04419-4","article-title":"Incidence and risk factors of heart failure with preserved ejection fraction in elderly patients with hypertension","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.08.086_bib210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI105748","article-title":"Studies on the characteristics of the control system governing sodium excretion in uremic man","volume":"47","author":"Slatopolsky","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2025.08.086_bib211","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/ki.2011.23","article-title":"The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder","volume":"79121","author":"Slatopolsky","year":"2011","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.jacc.2025.08.086_bib212","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.16033","article-title":"Evaluation of renal sodium handling in heart failure with preserved ejection fraction: a pilot study","volume":"12","author":"Agarwal","year":"2024","journal-title":"Physiol Rep"},{"issue":"21","key":"10.1016\/j.jacc.2025.08.086_bib213","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022542","article-title":"Role of renal sympathetic nerves in GLP-1 (Glucagon-Like Peptide-1) receptor agonist exendin-4-mediated diuresis and natriuresis in diet-induced obese rats","volume":"10","author":"Liu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.086_bib214","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1210\/jc.2003-031403","article-title":"Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men","volume":"89","author":"Gutzwiller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2025.08.086_bib215","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.soard.2017.04.002","article-title":"Urinary sodium excretion after gastric bypass surgery","volume":"13","author":"Docherty","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jacc.2025.08.086_bib216","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib217","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1159\/000491056","article-title":"Adenine-induced chronic renal failure in rats: a model of chronic renocardiac syndrome with left ventricular diastolic dysfunction but preserved ejection fraction","volume":"43","author":"Kashioulis","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jacc.2025.08.086_bib218","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1681\/ASN.2008080882","article-title":"Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease","volume":"20","author":"Schrier","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.jacc.2025.08.086_bib219","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/diagnostics14121310","article-title":"The association between echocardiographic parameters of heart failure with preserved ejection fraction and fluid status biomarkers in hemodialysis patients","volume":"14","author":"Lupa","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12872-024-03985-x","article-title":"Left ventricular geometry characteristics and clinical outcomes in hemodialysis patients with heart failure with preserved ejection fraction","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.08.086_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1130618","article-title":"Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis","volume":"10","author":"Malik","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.086_bib222","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/ehf2.14447","article-title":"Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis","volume":"10","author":"Yu","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib223","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","article-title":"Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jacc.2025.08.086_bib224","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ahj.2009.10.009","article-title":"The impact of kidney transplantation on heart failure risk varies with candidate body mass index","volume":"158","author":"Lentine","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.08.086_bib225","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib226","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1681\/ASN.2006040367","article-title":"Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease","volume":"18","author":"Tatematsu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2025.08.086_bib227","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/HJH.0b013e328345ef7b","article-title":"Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension","volume":"29","author":"Gao","year":"2011","journal-title":"J Hypertens"},{"issue":"21","key":"10.1016\/j.jacc.2025.08.086_bib228","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.3390\/nu14214664","article-title":"Left ventricular diastolic dysfunction in chronic kidney disease patients not treated with dialysis","volume":"14","author":"Romejko","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jacc.2025.08.086_bib229","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jacc.2024.08.028","article-title":"Inflammation in obesity-related HFpEF: the STEP-HFpEF program","volume":"84","author":"Verma","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacc.2025.08.086_bib230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201836","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction","volume":"13","author":"DuBrock","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.086_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131818","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: findings from TOPCAT","volume":"402","author":"Ferreira","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib232","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","article-title":"Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"94","author":"Reddy","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.08.086_bib233","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2025.08.086_bib234","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.11.149","article-title":"FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice","volume":"138","author":"Han","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.745892","article-title":"Cardiac fibroblast growth factor 23 excess does not induce left ventricular hypertrophy in healthy mice","volume":"9","author":"Leifheit-Nestler","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"10.1016\/j.jacc.2025.08.086_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100723","article-title":"Fibroblast growth factor 23 and risk of heart failure subtype: the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"5","author":"Leidner","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.jacc.2025.08.086_bib237","article-title":"Baseline fibroblast growth factor 23 predicts incident heart failure and cardiovascular mortality in patients with chronic kidney disease: a 3-year follow-up study","volume":"56","author":"Wang","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"15","key":"10.1016\/j.jacc.2025.08.086_bib238","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024952","article-title":"Fibroblast growth factor 23 and risk of new onset heart failure with preserved or reduced ejection fraction: the PREVEND study","volume":"11","author":"Binnenmars","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"10.1016\/j.jacc.2025.08.086_bib239","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008334","article-title":"Fibroblast growth factor-23 and heart failure with reduced versus preserved ejection fraction: MESA","volume":"7","author":"Almahmoud","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.086_bib240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cardfail.2020.09.477","article-title":"Fibroblast growth factor 23 and exercise capacity in heart failure with preserved ejection fraction","volume":"27","author":"Ghuman","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib241","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1002\/ehf2.13020","article-title":"Fibroblast-growth-factor-23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes","volume":"7","author":"Kanagala","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib242","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/ehf2.12816","article-title":"Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction","volume":"7","author":"Roy","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib243","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/eci.12349","article-title":"FGF23 is associated with disease severity and prognosis in chronic heart failure","volume":"44","author":"Poelzl","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.jacc.2025.08.086_bib244","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae141","article-title":"Targeted deletion of fibroblast growth factor 23 rescues metabolic dysregulation of diet-induced obesity in female mice","volume":"165","author":"Park","year":"2024","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clnu.2016.12.010","article-title":"Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation","volume":"37","author":"Hu","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jacc.2025.08.086_bib246","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110620","article-title":"The relationship between FGF23 and body composition according to albuminuria stage in type 1 diabetes","volume":"198","author":"Parente","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2025.08.086_bib247","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/09513590.2019.1689550","article-title":"Fibroblast growth factor 23 and 25(OH)D levels are related to abdominal obesity and cardiovascular risk in patients with polycystic ovarian syndrome","volume":"36","author":"Gateva","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jacc.2025.08.086_bib248","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cen.13981","article-title":"Fibroblast growth factor 23 levels decline following sleeve gastrectomy","volume":"91","author":"Billington","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacc.2025.08.086_bib249","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2290","article-title":"The Ngal reporter mouse detects the response of the kidney to injury in real time","volume":"17","author":"Paragas","year":"2011","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.086_bib250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/17446651.3.1.29","article-title":"Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein","volume":"3","author":"Hoo","year":"2008","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.jacc.2025.08.086_bib251","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120196","article-title":"Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury","volume":"3","author":"Sun","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacc.2025.08.086_bib252","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fphys.2019.01108","article-title":"Chronic kidney disease as a risk factor for heart failure with preserved ejection fraction: a focus on microcirculatory factors and therapeutic targets","volume":"10","author":"van de Wouw","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib253","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1523-1755.2005.00421.x","article-title":"Pathogenesis of vascular calcification in chronic kidney disease","volume":"68","author":"Cozzolino","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2025.08.086_bib254","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jchf.2024.12.007","article-title":"Association of extracoronary calcification and incident heart failure in the Multiethnic Study of Atherosclerosis (MESA)","volume":"13","author":"Brar","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.086_bib255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2016.08.004","article-title":"Predictors of abdominal aortic calcification progression in patients with chronic kidney disease without hemodialysis","volume":"253","author":"Yamamoto","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2025.08.086_bib256","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1038\/oby.2011.70","article-title":"The association between abdominal body composition and vascular calcification","volume":"19","author":"Jensky","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacc.2025.08.086_bib257","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.amjcard.2009.04.019","article-title":"Relation of subcutaneous and visceral adipose tissue to coronary and abdominal aortic calcium (from the Framingham Heart Study)","volume":"104","author":"Fox","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.086_bib258","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/oby.2010.30","article-title":"Regional adipose tissue associations with calcified atherosclerotic plaque: African American-diabetes heart study","volume":"18","author":"Divers","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacc.2025.08.086_bib259","doi-asserted-by":"crossref","first-page":"F689","DOI":"10.1152\/ajprenal.00584.2016","article-title":"Chronic kidney disease promotes chronic inflammation in visceral white adipose tissue","volume":"312","author":"Xiang","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.08.086_bib260","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/toxins15030179","article-title":"Advanced oxidation protein products contribute to chronic-kidney-disease-induced adipose inflammation through macrophage activation","volume":"15","author":"Arimura","year":"2023","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.086_bib261","article-title":"Adipose tissue metabolic changes in chronic kidney disease","volume":"5","author":"Serrano","year":"2023","journal-title":"Immunometabolism (Cobham)"},{"key":"10.1016\/j.jacc.2025.08.086_bib262","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/jcmm.13071","article-title":"Human adipose stromal cell therapy improves survival and reduces renal inflammation and capillary rarefaction in acute kidney injury","volume":"21","author":"Collett","year":"2017","journal-title":"J Cell Mol Med"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725076983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725076983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T01:25:17Z","timestamp":1766193917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725076983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":262,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0735109725076983"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.086","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Kidney Disease in Patients With Heart Failure With a Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}